The Financial Express8h
M&E deal activity to gain pace in FY26
Following a year of significant deals, India's media and entertainment (M&E) sector is expected to focus on strategic, ...
Temasek’s 65 Equity makes Europe foray with Swiss pharma merger
It is financing Healthcare Advanced Synthesis’ acquisition of Cerbios-Pharma and taking a 40 per cent stake in merged entity.
The Manila Times57m
Stefanini Group focuses on global leadership with AI First concept
According to Guilherme Stefanini, Global CMO of the Stefanini Group, "With the mergers and acquisitions, we greatly increased ...
The Business Times8h
Temasek-backed 65 Equity Partners makes Europe foray with Swiss pharma merger
LONDON] Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis’ (HAS ...
HPE CEO optimistic over 'transformative' Juniper acquisition
Hewlett Packard Enterprise (NYSE:HPE) is confident it's on the right side of the argument when it faces the U.S. Department ...
Korea JoongAng Daily on MSN3h
Balaan files for corporate rehabilitation after failing to pay sellers for week
Balaan suspended all new purchases on Friday afternoon, having reportedly failed to pay out its sellers for the past week.
Elon Musk buys X, again! Here’s how XAI Holdings delivers for investors — Key questions answered
Elon Musk has acquired Twitter for a second time using his AI startup xAI. The merged entity, called XAI Holdings is now valued over $100 billion — delivering a win for investors. But what does this ...
Under pressure: Companies spend token amounts for ads on X to avoid getting on Musk's bad side
In the US, ad spending on X declined by 2 per cent in the first two months of 2025 compared with the previous year, even as firms like Hulu and Unilever cautiously returned to the platform. American ...